OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of cancer with antipsychotic medications: Pushing the boundaries of schizophrenia and cancer
James S. Brown
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104809-104809
Closed Access | Times Cited: 19

Showing 19 citing articles:

Targeting autophagy by antipsychotic phenothiazines: potential drug repurposing for cancer therapy
Rayssa de Mello Lopes, Ana Carolina Santos de Souza, Michał Otręba, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116075-116075
Closed Access | Times Cited: 5

Single‐cell characterization of differentiation trajectories and drug resistance features in gastric cancer with peritoneal metastasis
Haoxin Peng, Lei Jiang, Jiajia Yuan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 10
Open Access | Times Cited: 5

Effects of mind-body therapies on schizophrenia: A systematic review and network meta-analysis
Yuqin Su, Xiaoli Pan, Hansen Li, et al.
Schizophrenia Research (2024) Vol. 264, pp. 236-247
Closed Access | Times Cited: 4

Severe Mental Disorders and Cancer
Ivona Šimunović Filipčić, Luigi Grassi, Igor Filipčić
(2025), pp. 203-220
Closed Access

The causal relationship between severe mental illness and risk of lung carcinoma
Xiaohan Chen, Shudan Wang, Weiyu Shen
Medicine (2024) Vol. 103, Iss. 11, pp. e37355-e37355
Open Access | Times Cited: 2

Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model
JR-DI YANG, Yu‐Chang Liu, Hsiao‐Chia Wang, et al.
In Vivo (2024) Vol. 38, Iss. 3, pp. 1079-1093
Open Access | Times Cited: 2

Dissecting the novel abilities of aripiprazole: The generation of anti-colorectal cancer effects by targeting Gαq via HTR2B
Haowei Liu, Qiuming Huang, Yunqi Fan, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3400-3413
Open Access | Times Cited: 5

Voltammetric Sensor for Doxorubicin Determination Based on Self-Assembled DNA-Polyphenothiazine Composite
Anastasia N Malanina, Yurii Kuzin, Alena I. Khadieva, et al.
Nanomaterials (2023) Vol. 13, Iss. 16, pp. 2369-2369
Open Access | Times Cited: 4

Comparison of Oncogenes, Tumor Suppressors, and MicroRNAs Between Schizophrenia and Glioma: The Balance of Power
James S. Brown
Neuroscience & Biobehavioral Reviews (2023) Vol. 151, pp. 105206-105206
Closed Access | Times Cited: 4

Causality between six psychiatric disorders and digestive tract cancers risk: a two-sample Mendelian randomization study
Qi Fu, Ling‐Hui Li, Niyang Zhuoma, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

In vitro cytotoxic activity of chemically synthesized ZnTe nanoparticles against human lung cancer cell line L-132 with supported molecular docking study
Sanghita Basak, Aveepsa Sengupta, Snehasish Modak, et al.
Materials Chemistry and Physics (2024) Vol. 326, pp. 129774-129774
Closed Access | Times Cited: 1

The anti-cancer efficacy of a novel phenothiazine derivative is independent of dopamine and serotonin receptor inhibition
Marion Vanneste, Anita Venzke, Soumitra Guin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3

Establishment of LC–MS/MS method for quantifying chlorpromazine metabolites with application to its metabolism in liver and placenta microsomes
Tiantian Fu, Bingyi Yao, Yuanqing Guo, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 233, pp. 115457-115457
Closed Access | Times Cited: 2

First-Line Combination Treatment with Low-Dose Bipolar Drugs for ABCB1-Overexpressing Drug-Resistant Cancer Populations
Sungpil Yoon, Hyung Sik Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8389-8389
Open Access | Times Cited: 2

Proteomic Analysis of the Molecular Mechanisms of Chlorpromazine Inhibiting Migration of Oral Squamous Cell Carcinoma
Nannan Zhang, Junzhi Liu, Qiuping Dong, et al.
Current Proteomics (2024) Vol. 21, Iss. 1, pp. 2-13
Closed Access

Iloperidone and Temozolomide Synergistically Inhibit Growth, Migration and Enhance Apoptosis in Glioblastoma Cells
Sahar Mubeen, Iffat Raza, Badaruddin Ujjan, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1134-1134
Open Access

Repurposing the antipsychotic drug penfluridol for cancer treatment (Review)
Asma Ali Ibrahim Mze, Amirah Abdul Rahman
Oncology Reports (2024) Vol. 52, Iss. 6
Open Access

Page 1

Scroll to top